It is inefficient as an HSP coinducing agent in motor neurons, yet it protects against some measures of toxicity in ALS models, including the FUS model, which was the least responsive in terms of HSPA1A induction and preservation of Hspa8 mRNA expression. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.